Viibryd and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viibryd (vilazodone hydrochloride) and Ergocalciferol (ergocalciferol). Common drug interactions include death among females and arthropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Viibryd and Ergocalciferol. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.



On Jul, 14, 2026

91 people who take Viibryd and Ergocalciferol together, and have interactions are studied.

Viibryd and Ergocalciferol drug interactions.

What are the common drug interactions of Viibryd and Ergocalciferol, by gender? *:

female:

  1. Death
  2. Fall
  3. Feeling jittery
  4. Gout (uric acid crystals building up in the body)
  5. Heart rate decreased
  6. Histoplasmosis (infection caused by breathing in spores of a fungus)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Iron deficiency
  9. Mycobacterium avium complex infection
  10. Post procedural haemorrhage (post procedural bleeding)

male:

  1. Arthropathy
  2. Gastric ph increased
  3. Injection site swelling
  4. Orchitis (inflammation of the testes)
  5. Respiratory disorder (respiratory disease)
  6. Sinusitis (inflammation of sinus)
  7. Chronic kidney disease
  8. Prostate infection
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Back pain

What are the common drug interactions of Viibryd and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Mood altered (changes in mood)
  2. Myalgia (muscle pain)
  3. Suicidal ideation

30-39:

  1. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)

40-49:

  1. Muscle spasms (muscle contraction)
  2. Shoulder operation
  3. Upper respiratory tract infection
  4. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  5. Arthralgia (joint pain)
  6. Dizziness

50-59:

  1. Oral candidiasis (fungal infection of mouth)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Peroneal nerve palsy
  5. Pneumonia
  6. Pulmonary arterial pressure increased
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Renal impairment (severely reduced kidney function)
  9. Renal transplant
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Chronic kidney disease
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Abdominal discomfort
  5. Abdominal pain upper
  6. Alopecia (absence of hair from areas of the body)
  7. Chest pain
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Diarrhoea
  10. Enteritis (inflammation of the small intestine)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 46 people, 50.55%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 39 people, 42.86%
  3. Pain: 15 people, 16.48%
  4. Drowsiness: 8 people, 8.79%
  5. Stress And Anxiety: 6 people, 6.59%
  6. Nausea (feeling of having an urge to vomit): 6 people, 6.59%
  7. Asthma: 6 people, 6.59%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 5.49%
  9. Immunodeficiency Common Variable: 5 people, 5.49%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viibryd and Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viibryd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ergocalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vilazodone hydrochloride and ergocalciferol (the active ingredients of Viibryd and Ergocalciferol, respectively), and Viibryd and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: